http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102391287-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9702f76fd6bc7f59d1daa4d78bf3d1c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2011-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ada111ddbeb8e9d39d83ded7c4aa7855
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ea65e47d20756bf16dd4ac68299070b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5b317f38279981ee4a2d7a25449cd7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3878737c453879a2e392ee181cbea138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_804d96035b2a9bf2787567f54b9b1a09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_864d2ea06f6dcad370356337f54b809c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaa3343983ff92abca39e89bf6535918
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6459f5f44555d16a2d08ff2932240522
publicationDate 2012-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102391287-A
titleOfInvention Levofluoroquinolone C3 bisazole methyl sulfide, preparation method and application thereof
abstract The invention belongs to the technical field of medicine, and specifically discloses a levofluoroquinolone C3 bisazole methide, and also discloses a preparation method of the levofluoroquinolone C3 bisazole methide and its application in the field of pharmacy. The chemical structural formula of levofluoroquinolone C3 bisazole methyl sulfide is shown in general formula I: General formula I, wherein, X is selected from any of O, S, -NH; Ar is selected from any of phenyl, phenyl with substituents, and heterocyclic aromatic hydrocarbon groups. The levofluoroquinolone C3 bisazole methyl sulfide provided by the present invention has a strong in vitro cytotoxic effect on experimental leukemia cancer cell lines, and has strong antitumor activity, and can be salt-formed with a human acceptable acid or with a pharmaceutical carrier. Mix to prepare antitumor drugs.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104592252-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104497014-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109678881-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104628702-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109761997-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109761997-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104592252-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104628702-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104829655-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104557974-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109762005-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109762004-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109761999-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109678890-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109761998-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109678889-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109761998-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109678883-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109678882-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109678885-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109678884-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104497014-B
priorityDate 2011-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008013987-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007238720-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009069560-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465239202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60143711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465941137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532884
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465319714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71766511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60143385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60143884
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428475235

Total number of triples: 54.